Skip to main content
. 2022 Mar 11;13:816460. doi: 10.3389/fgene.2022.816460

TABLE 1.

Clinical features of all patients.

Feature Group TARGET dataset (n = 84)
Number of patients (%)
Age <16 48 (57.1)
≥16 36 (42.9)
Gender Female 36 (42.9)
Male 48 (57.1)
Metastatic Metastatic 21 (25.0)
Non-metastatic 63 (75.0)
Histologic response Stage 1/2 18 (21.4)
Stage 3/4 16 (19.0)
Vital status Alive 55 (65.5)
Dead 29 (34.5)